Summary
48 / 100 · Bulios Score
What speaks for it
- It could repay all its net debt from 1.0 years of operating profit.
- It has been profitable 6 years in a row.
What to watch
- It pays out more in dividends than it earns: 239% of profit.
- The share price is above the Bulios Fair Price.
- Earnings per share fell by 6.3% a year over the last 3 years.
- Out of every 100 USD of revenue, only 1.7 USD is left as net profit.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 30.2 USD for 1 USD of yearly profit. Over the last five years it was 48.9 USD on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 10% a year over 5 years. Over the last 3 years it grew by 7.5% a year. Earnings per share fell by 6.3% a year over the last 3 years.
Growth in detailDoes it make money?
PoorlyWhere 100 USD of revenue goes
- Cost of sales 77 USD
- Research and development 8.0 USD
- Sales and administration 19 USD
- Taxes and other 3.4 USD
- Net profit 0.8 USD
Net profit, industry median (Auto - Parts) 4.9 USD
Out of every 100 USD of revenue, 0.8 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesRepaying all its debt would take 2.6 years of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
High, at risk- Yield
- 7.92%
- Paid out of profit
- 239%
The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 9
- Hold 6
- Sell 0
Today's price within the analysts' price targets
The average target of $47.67 is 67% above today's price. 60% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Automotive Segments 97%
- Medical Segments 3.3%
By region
- Non-US 40%
- UNITED STATES 21%
- CHINA 9.8%
- Other Countries 8.0%
- GERMANY 4.6%
- Other 16%
Automotive Segments brings in 97% of revenue.
Segments in detail